Literature DB >> 28120933

Where There is Smoke There is Fear-Impaired Contextual Inhibition of Conditioned Fear in Smokers.

Jan Haaker1,2, Tina B Lonsdorf2, Dirk Schümann2, Nico Bunzeck2,3, Jan Peters2,4, Tobias Sommer2, Raffael Kalisch2,5,6.   

Abstract

The odds-ratio of smoking is elevated in populations with neuropsychiatric diseases, in particular in the highly prevalent diagnoses of post-traumatic stress and anxiety disorders. Yet, the association between smoking and a key dimensional phenotype of these disorders-maladaptive deficits in fear learning and fear inhibition-is unclear. We therefore investigated acquisition and memory of fear and fear inhibition in healthy smoking and non-smoking participants (N=349, 22% smokers). We employed a well validated paradigm of context-dependent fear and safety learning (day 1) including a memory retrieval on day 2. During fear learning, a geometrical shape was associated with an aversive electrical stimulation (classical fear conditioning, in danger context) and fear responses were extinguished within another context (extinction learning, in safe context). On day 2, the conditioned stimuli were presented again in both contexts, without any aversive stimulation. Autonomic physiological measurements of skin conductance responses as well as subjective evaluations of fear and expectancy of the aversive stimulation were acquired. We found that impairment of fear inhibition (extinction) in the safe context during learning (day 1) was associated with the amount of pack-years in smokers. During retrieval of fear memories (day 2), smokers showed an impairment of contextual (safety context-related) fear inhibition as compared with non-smokers. These effects were found in physiological as well as subjective measures of fear. We provide initial evidence that smokers as compared with non-smokers show an impairment of fear inhibition. We propose that smokers have a deficit in integrating contextual signs of safety, which is a hallmark of post-traumatic stress and anxiety disorders.

Entities:  

Mesh:

Year:  2017        PMID: 28120933      PMCID: PMC5518897          DOI: 10.1038/npp.2017.17

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  26 in total

Review 1.  Post-traumatic stress disorder and smoking: a systematic review.

Authors:  Steven S Fu; Miles McFall; Andrew J Saxon; Jean C Beckham; Timothy P Carmody; Dewleen G Baker; Anne M Joseph
Journal:  Nicotine Tob Res       Date:  2007-11       Impact factor: 4.244

Review 2.  Fear extinction and relapse: state of the art.

Authors:  Bram Vervliet; Michelle G Craske; Dirk Hermans
Journal:  Annu Rev Clin Psychol       Date:  2013       Impact factor: 18.561

3.  A twin registry study of the relationship between posttraumatic stress disorder and nicotine dependence in men.

Authors:  Karestan C Koenen; Brian Hitsman; Michael J Lyons; Raymond Niaura; Jeanne McCaffery; Jack Goldberg; Seth A Eisen; William True; Ming Tsuang
Journal:  Arch Gen Psychiatry       Date:  2005-11

4.  The effects of acute nicotine on contextual safety discrimination.

Authors:  Munir G Kutlu; Chicora Oliver; Thomas J Gould
Journal:  J Psychopharmacol       Date:  2014-09-29       Impact factor: 4.153

5.  Smoking in help-seeking veterans with PTSD returning from Afghanistan and Iraq.

Authors:  A C Kirby; B P Hertzberg; C F Collie; B Yeatts; M F Dennis; S D McDonald; P S Calhoun; J C Beckham
Journal:  Addict Behav       Date:  2008-05-22       Impact factor: 3.913

6.  Effects of Smoking Cessation on Presynaptic Dopamine Function of Addicted Male Smokers.

Authors:  Lena Rademacher; Susanne Prinz; Oliver Winz; Karsten Henkel; Claudia A Dietrich; Jörn Schmaljohann; Siamak Mohammadkhani Shali; Ina Schabram; Christian Stoppe; Paul Cumming; Ralf-Dieter Hilgers; Yoshitaka Kumakura; Mark Coburn; Felix M Mottaghy; Gerhard Gründer; Ingo Vernaleken
Journal:  Biol Psychiatry       Date:  2015-12-01       Impact factor: 13.382

7.  Psychiatric disorders and stages of smoking.

Authors:  Naomi Breslau; Scott P Novak; Ronald C Kessler
Journal:  Biol Psychiatry       Date:  2004-01-01       Impact factor: 13.382

8.  Dopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.

Authors:  Michael A P Bloomfield; Fiona Pepper; Alice Egerton; Arsime Demjaha; Gianpaolo Tomasi; Elias Mouchlianitis; Levi Maximen; Mattia Veronese; Federico Turkheimer; Sudhakar Selvaraj; Oliver D Howes
Journal:  Neuropsychopharmacology       Date:  2014-04-10       Impact factor: 7.853

9.  Single dose of L-dopa makes extinction memories context-independent and prevents the return of fear.

Authors:  Jan Haaker; Stefano Gaburro; Anupam Sah; Nina Gartmann; Tina B Lonsdorf; Kolja Meier; Nicolas Singewald; Hans-Christian Pape; Fabio Morellini; Raffael Kalisch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

10.  Toward the future of psychiatric diagnosis: the seven pillars of RDoC.

Authors:  Bruce N Cuthbert; Thomas R Insel
Journal:  BMC Med       Date:  2013-05-14       Impact factor: 8.775

View more
  3 in total

1.  Tyrosine receptor kinase B receptor activation reverses the impairing effects of acute nicotine on contextual fear extinction.

Authors:  Munir Gunes Kutlu; Robert D Cole; David A Connor; Brendan Natwora; Thomas J Gould
Journal:  J Psychopharmacol       Date:  2018-03-01       Impact factor: 4.153

2.  Smokers show increased fear responses towards safety signals during fear generalization, independent from acute smoking.

Authors:  Madeleine Mueller; Smilla Weisser; Jonas Rauh; Jan Haaker
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

3.  Dopamine Related Genes Differentially Affect Declarative Long-Term Memory in Healthy Humans.

Authors:  Carla Leukel; Dirk Schümann; Raffael Kalisch; Tobias Sommer; Nico Bunzeck
Journal:  Front Behav Neurosci       Date:  2020-10-28       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.